← Leaderboards
Keith Syson Chan
Methodist Hospital Research Institute
$11,391,028
Attributed
$12,956,079
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,827,971 · 14
By mechanism
U54$11,772,921 · 10
R01$7,011,387 · 2
R00$839,529 · 1
K99$204,134 · 1
Top collaborators
- Dan Theodorescu11 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Dan Theodorescu$43,145,134
- Qi Cao$5,501,009
Others in their field
Top investigators on “Malignant Neoplasm Of Urinary Bladder”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- Walter John Curran · Thomas Jefferson University$36,890,150
- Norman Wolmark · Nsabp Foundation, Inc.$33,598,810
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$33,598,810
- Quynh-Thu X Le · Stanford University$23,198,964
- Larry Arthur$21,899,494
Research focus
Malignant Neoplasm Of Urinary BladderMalignant NeoplasmsSignal TransductionMediatingFundingSuccessTumorCellsPropertyBladder NeoplasmNeoplastic CellGenesFibroblastsIn VivoRegulationInnovationReportingCancer CellBioinformaticsReceptorBiologicalCancer TypeNuclearProteins
Grant awards (45)
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,646,006
U54 · FY2025 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$452,797
R01 · FY2025 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$385,560
R01 · FY2025 · CA · contact PI
Project 1$356,139
U54 · FY2025 · CA · contact PI
Administrative Core$311,592
U54 · FY2025 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,564,827
U54 · FY2024 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$434,475
R01 · FY2024 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$373,783
R01 · FY2024 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$363,685
R01 · FY2024 · CA · contact PI
Project 1$338,607
U54 · FY2024 · CA · contact PI
Administrative Core$296,234
U54 · FY2024 · CA · contact PI
A single-cell spatial map characterizing the stromal TME in bladder and breast early-lesions$174,625
U54 · FY2024 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,657,891
U54 · FY2023 · CA · contact PI
Project-004$822,274
U54 · FY2023 · CA · contact PI
Project-006$765,000
U54 · FY2023 · CA · contact PI
Project-005$636,346
U54 · FY2023 · CA · contact PI
Core-002$562,163
U54 · FY2023 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$418,910
R01 · FY2023 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$400,962
R01 · FY2023 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$382,828
R01 · FY2023 · CA · contact PI
Admin-Core-002$344,319
U54 · FY2023 · CA · contact PI
Spatial and mechanistic assessment of the role of stromal fibroblasts in driving emergence of aggressive prostate and bladder cancer$83,500
U54 · FY2023 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,745,043
U54 · FY2022 · CA · contact PI
Project 1$392,658
U54 · FY2022 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$226,446
R01 · FY2022 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$204,580
R01 · FY2022 · CA · contact PI
Administrative Core$75,697
U54 · FY2022 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$1
R01 · FY2022 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$1
R01 · FY2022 · CA · contact PI
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance$472,650
R01 · FY2021 · CA · contact PI
A vicious cycle of pyroptotic cancer cells and fibroblasts fuels chemoresistance$390,397
R01 · FY2021 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$380,402
R01 · FY2021 · CA · contact PI
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches$399,013
R01 · FY2020 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$110,950
R01 · FY2018 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$324,738
R01 · FY2017 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$324,738
R01 · FY2016 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$324,738
R01 · FY2015 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$314,995
R01 · FY2014 · CA · contact PI
Cancer-associated fibroblast in the regulation of bladder cancer stem cells$324,738
R01 · FY2013 · CA · contact PI
Identification and characterization of bladder cancer stem cells$241,529
R00 · FY2011 · CA · contact PI
Identification and characterization of bladder cancer stem cells$249,000
R00 · FY2010 · CA · contact PI
Identification and characterization of bladder cancer stem cells$249,000
R00 · FY2009 · CA · contact PI
Identification and characterization of bladder cancer stem cells$100,000
R00 · FY2009 · CA · contact PI
Identification and characterization of bladder cancer stem cells$103,097
K99 · FY2008 · CA · contact PI
Identification and characterization of bladder cancer stem cells$101,037
K99 · FY2007 · CA · contact PI